BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38217112)

  • 1. Early diagnosis and management of cardiac amyloidosis: A clinical perspective.
    Bellofatto IA; Schindler TH; Portincasa P; Carbone F; Canepa M; Liberale L; Montecucco F
    Eur J Clin Invest; 2024 Jun; 54(6):e14160. PubMed ID: 38217112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What should we know about cardiac amyloidosis? From clinical signs to treatment].
    Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z
    Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac amyloidosis : simplifying the diagnosis of a complex disease].
    Dayer N; Monney P; Hugelshofer S
    Rev Med Suisse; 2024 May; 20(875):1010-1017. PubMed ID: 38783670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
    Feldmann K; Hamm CW; Aßmus B
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
    J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
    Khedraki R
    Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis.
    Law S; Fontana M; Gillmore JD
    Cardiol Clin; 2021 Aug; 39(3):389-402. PubMed ID: 34247752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
    Gertz MA; Benson MD; Dyck PJ; Grogan M; Coelho T; Cruz M; Berk JL; Plante-Bordeneuve V; Schmidt HHJ; Merlini G
    J Am Coll Cardiol; 2015 Dec; 66(21):2451-2466. PubMed ID: 26610878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac amyloidosis and aortic stenosis: what do we know?].
    Sena G; Ruotolo I; Zaccaro A; Ponziani A; Saturi G; Gagliardi C; Biagini E; Longhi S
    G Ital Cardiol (Rome); 2024 Jul; 25(7):483-490. PubMed ID: 38916463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
    Griffin JM; Maurer MS
    Trends Cardiovasc Med; 2021 Jan; 31(1):59-66. PubMed ID: 31889610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician.
    Castiglione V; Aimo A; Vergaro G
    Int J Cardiol; 2024 May; 402():131855. PubMed ID: 38360098
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management.
    Marcu CB; Niessen HW; Beek AM; Brouwer WP; Robbers LF; Van Rossum AC
    Conn Med; 2011; 75(10):581-90. PubMed ID: 22216672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis.
    Griffin JM; Rosenblum H; Maurer MS
    Circ Res; 2021 May; 128(10):1554-1575. PubMed ID: 33983835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.